Null models for the effect of combination therapies are widely used to evaluate synergy and antagonism of drugs. Due to the relevance of null models, their suitability is continuously discussed. Here, we contribute to the discussion by investigating the properties of five null models. Our study includes the model proposed by David J. Hand, which we refer to as Hand model. The Hand model has been introduced almost 20 years ago but hardly was used and studied. We show that the Hand model generalizes the principle of dose equivalence compared to the Loewe model and resolves the ambiguity of the Tallarida model. This provides a solution to the persisting conflict about the compatibility of two essential model properties: the sham combination principle and the principle of dose equivalence. By embedding several null models into a common framework, we shed light in their biochemical validity and provide indications that the Hand model is biochemically most plausible. We illustrate the practical implications and differences between null models by examining differences of null models on published data.

Null models for the effect of combination therapies are widely used to evaluate synergy and antagonism of drugs. Due to the relevance of null models, their suitability is continuously discussed. Here, we contribute to the discussion by investigating the properties of five null models. Our study includes the model proposed by David J. Hand, which we refer to as Hand model. The Hand model has been introduced almost 20 years ago but hardly was used and studied. We show that the Hand model generalizes the principle of dose equivalence compared to the Loewe model and resolves the ambiguity of the Tallarida model. This provides a solution to the persisting conflict about the compatibility of two essential model properties: the sham combination principle and the principle of dose equivalence. By embedding several null models into a common framework, we shed light in their biochemical validity and provide indications that the Hand model is biochemically most plausible. We illustrate the practical implications and differences between null models by examining differences of null models on published data.

A minimal model for gene expression, consisting of a switchable promoter together with the resulting messenger RNA, is equivalent to a Poisson channel with a binary Markovian input process. Determining its capacity is an optimization problem with respect to two parameters: the average sojourn times of the promoter's active (ON) and inactive (OFF) state. An expression for the mutual information is found by solving the associated filtering problem analytically on the level of distributions. For fixed peak power, three bandwidth-like constraints are imposed by lower-bounding (i) the average sojourn times (ii) the autocorrelation time and (iii) the average time until a transition. OFFfavoring optima are found for all three constraints, as commonly encountered for the Poisson channel. In addition, constraint (i) exhibits a region that favors the ON state, and (iii) shows ONfavoring local optima.